ASX - By Stock
|
REP |
Re:
Ann: Half Yearly Report and Accounts
|
|
rvajna
|
7 |
1.6K |
0 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
7
|
1.6K
|
0
|
|
ASX - By Stock
|
LOT |
Re:
LOT Chart
|
|
rvajna
|
201 |
80K |
1 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
201
|
80K
|
1
|
|
ASX - By Stock
|
LOT |
Re:
LOT Chart
|
|
rvajna
|
201 |
80K |
0 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
201
|
80K
|
0
|
|
ASX - By Stock
|
LOT |
Re:
LOT Chart
|
|
rvajna
|
201 |
80K |
1 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
201
|
80K
|
1
|
|
ASX - By Stock
|
TIE |
Re:
Ann: Takeover - extension of offer period
|
|
rvajna
|
12 |
1.8K |
0 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
12
|
1.8K
|
0
|
|
ASX - By Stock
|
WGX |
Re:
Ann: Corporate Presentation - Swiss Mining Institute
|
|
rvajna
|
7 |
1.5K |
1 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
7
|
1.5K
|
1
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Suspension from Quotation
|
|
rvajna
|
51 |
10K |
1 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
51
|
10K
|
1
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Suspension from Quotation
|
|
rvajna
|
51 |
10K |
0 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
51
|
10K
|
0
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Suspension from Quotation
|
|
rvajna
|
51 |
10K |
2 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
51
|
10K
|
2
|
|
ASX - By Stock
|
LOT |
Re:
LOT Chart
|
|
rvajna
|
201 |
80K |
1 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
201
|
80K
|
1
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Suspension from Quotation
|
|
rvajna
|
51 |
10K |
6 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
51
|
10K
|
6
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Osteopore secures Singapore and Vietnam market approvals
|
|
rvajna
|
49 |
16K |
0 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
49
|
16K
|
0
|
|
ASX - By Stock
|
CRN |
Re:
Just bought in..... ᕙ༼◕ ᴥ ◕༽ᕗ
|
|
rvajna
|
6 |
1.5K |
1 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
6
|
1.5K
|
1
|
|
ASX - By Stock
|
PGC |
Re:
Ann: AGM Presentation
|
|
rvajna
|
37 |
18K |
1 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
37
|
18K
|
1
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Osteopore secures Singapore and Vietnam market approvals
|
|
rvajna
|
49 |
16K |
1 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
49
|
16K
|
1
|
|
ASX - By Stock
|
PEN |
Re:
Ann: A$10m SPP Closes Substantially Oversubscribed
|
|
rvajna
|
171 |
59K |
2 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
171
|
59K
|
2
|
|
ASX - By Stock
|
BOE |
Re:
Bearish Short Case - Stay Away If You Want Bullish News
|
|
rvajna
|
67 |
29K |
1 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
67
|
29K
|
1
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Prospectus for Renounceable Rights Issue
|
|
rvajna
|
45 |
13K |
0 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
45
|
13K
|
0
|
|
ASX - By Stock
|
LOT |
Re:
Ann: Change in substantial holding from MQG
|
|
rvajna
|
10 |
2.0K |
0 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
10
|
2.0K
|
0
|
|
ASX - By Stock
|
LOT |
Re:
LOT Chart
|
|
rvajna
|
201 |
80K |
0 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
201
|
80K
|
0
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Prospectus for Renounceable Rights Issue
|
|
rvajna
|
45 |
13K |
0 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
45
|
13K
|
0
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Osteopore secures Singapore and Vietnam market approvals
|
|
rvajna
|
49 |
16K |
1 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
49
|
16K
|
1
|
|
ASX - By Stock
|
DSE |
Re:
Ann: Investor Presentation Q4 2023 Update
|
|
rvajna
|
17 |
7.5K |
0 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
17
|
7.5K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Cleansing Notice
|
|
rvajna
|
2 |
959 |
4 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
2
|
959
|
4
|
|
ASX - By Stock
|
LOT |
Re:
LOT Chart
|
|
rvajna
|
201 |
80K |
0 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
201
|
80K
|
0
|
|
ASX - By Stock
|
LOT |
Re:
Ann: Change in substantial holding from MQG
|
|
rvajna
|
10 |
2.0K |
0 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
10
|
2.0K
|
0
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Osteopore secures Singapore and Vietnam market approvals
|
|
rvajna
|
49 |
16K |
1 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
49
|
16K
|
1
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Osteopore secures Singapore and Vietnam market approvals
|
|
rvajna
|
49 |
16K |
1 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
49
|
16K
|
1
|
|
ASX - By Stock
|
OSX |
Re:
Michael Keenan
|
|
rvajna
|
17 |
3.5K |
1 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
17
|
3.5K
|
1
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Prospectus for Renounceable Rights Issue
|
|
rvajna
|
45 |
13K |
1 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
45
|
13K
|
1
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Update - Consolidation/Split - OSX
|
|
rvajna
|
26 |
8.0K |
1 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
26
|
8.0K
|
1
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Osteopore secures Singapore and Vietnam market approvals
|
|
rvajna
|
49 |
16K |
3 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
49
|
16K
|
3
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Osteopore secures Singapore and Vietnam market approvals
|
|
rvajna
|
49 |
16K |
3 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
49
|
16K
|
3
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Osteopore secures Singapore and Vietnam market approvals
|
|
rvajna
|
49 |
16K |
2 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
49
|
16K
|
2
|
|
ASX - By Stock
|
LOT |
Re:
Ann: Change in substantial holding from MQG
|
|
rvajna
|
10 |
2.0K |
0 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
10
|
2.0K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
rvajna
|
181 |
71K |
4 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
181
|
71K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
rvajna
|
181 |
71K |
5 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
181
|
71K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
rvajna
|
449 |
138K |
1 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
449
|
138K
|
1
|
|
ASX - By Stock
|
AVZ |
Re:
Ann: AVZI Successfully Defends Against Jin Cheng ICC Proceedings
|
|
rvajna
|
353 |
151K |
2 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
353
|
151K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
rvajna
|
381 |
119K |
1 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
381
|
119K
|
1
|
|
ASX - By Stock
|
WEB |
Re:
Ann: WebBeds Strategy Day Investor Presentation
|
|
rvajna
|
10 |
3.8K |
1 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
10
|
3.8K
|
1
|
|
ASX - By Stock
|
CNJ |
Re:
Ann: Pro-Rata Non-Renounceable Rights Offer (Correction)
|
|
rvajna
|
30 |
5.7K |
0 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
30
|
5.7K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
rvajna
|
4.8K |
2.3M |
0 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
4.8K
|
2.3M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
rvajna
|
449 |
138K |
1 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
449
|
138K
|
1
|
|
ASX - By Stock
|
NEC |
Re:
Ann: Update - Notification of buy-back - NEC
|
|
rvajna
|
4 |
418 |
0 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
4
|
418
|
0
|
|
ASX - By Stock
|
CUP |
Re:
Ann: Change in substantial holding from CBA
|
|
rvajna
|
12 |
2.4K |
0 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
12
|
2.4K
|
0
|
|
ASX - By Stock
|
LOT |
Re:
Ann: Change in substantial holding from MQG
|
|
rvajna
|
10 |
2.0K |
0 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
10
|
2.0K
|
0
|
|
ASX - By Stock
|
LOT |
Re:
Ann: Change in substantial holding from MQG
|
|
rvajna
|
10 |
2.0K |
0 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
10
|
2.0K
|
0
|
|
ASX - By Stock
|
RMS |
Re:
The suspense is killing me
|
|
rvajna
|
27 |
11K |
4 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
27
|
11K
|
4
|
|
ASX - By Stock
|
NEC |
Re:
Ann: Update - Notification of buy-back - NEC
|
|
rvajna
|
3 |
467 |
1 |
25/03/24 |
25/03/24 |
ASX - By Stock
|
3
|
467
|
1
|
|